Blood manganese levels in patients with hepatic encephalopathy
详细信息    查看全文
文摘

Project

Hepatic encephalopathy is an increasingly common disease. Identification of prognosis risk factors in patients with liver damage may lead to preventive actions, towards decreasing its mortality. Manganese (Mn) levels are increased in basal ganglia of patients with hepatic encephalopathy as well as in cases of cirrhotic and liver failure patients. The present is a clinical, prospective, prolective and observational study developed at the Internal Medicine Service from ¡°Dr. Dar¨ªo Fern¨¢ndez Fierro?General Hospital, ISSSTE, Mexico City. The objective of this work was to report whole blood Mn levels and mortality in encephalopathic patients.

Procedure

Consecutive patients over 18 years of age, diagnosed with hepatic encephalopathy were recruited at the emergency room service. An informed consent, signed by their families was collected. Patients?clinical characteristics, biochemical tests of renal function, hemoglobin, glucose, bilirubins and albumin levels were obtained along with a blood sample to analyze Mn. Patients evolution was followed up for 6 months.

Results

Blood Mn in patients [median, (range)] [20.5, (10.5-39.5) ¦Ìg/L] were higher than blood levels from a group of healthy volunteers [7.5, (6.1-12.8) ¦Ìg/L] (P < 0.001). Among 9 patients studied four died, 2 women and 2 men, those patients showed higher (P = 0.032) Mn levels [28, (17-39.5) ¦Ìg/L] than those alive [13.5, (10.5-32) ¦Ìg/L] after the follow up period.

Conclusions

In this pilot study, Mn blood levels were higher in hepatic encephalopathy that died as consequence of the disease that those that survived in a 6 month follow up period. Blood Mn could be a potential prognosis factor for death in patients with hepatic encephalopathy.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700